|
Volumn 120, Issue 2, 2003, Pages 274-276
|
Successful treatment of acute myelomonocytic leukaemia with NUP98-HOXD11 fusion transcripts and monitoring of minimal residual disease
|
Author keywords
Acute myelomonocytic leukaemia; HOXD11; Minimal residual disease; NUP98; T(2; 11)(q31; p15)
|
Indexed keywords
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
ACUTE MYELOMONOCYTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CASE REPORT;
CHROMOSOME TRANSLOCATION 2;
DISEASE COURSE;
GENE FUSION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MALE;
MINIMAL RESIDUAL DISEASE;
PATIENT MONITORING;
PRIORITY JOURNAL;
UMBILICAL CORD BLOOD;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOSOMES, HUMAN, PAIR 11;
CHROMOSOMES, HUMAN, PAIR 2;
COMBINED MODALITY THERAPY;
CORD BLOOD STEM CELL TRANSPLANTATION;
GENE REARRANGEMENT;
HUMANS;
KARYOTYPING;
LEUKEMIA, MYELOMONOCYTIC, ACUTE;
MALE;
NEOPLASM, RESIDUAL;
ONCOGENE PROTEINS, FUSION;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
EID: 0037276058
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2003.04052.x Document Type: Article |
Times cited : (5)
|
References (8)
|